Also trades as: GLAB.CN (CNQ) · $vol 0M
GLABF OTC
Gemina Laboratories Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -85.1%
3Y: -90.5%
$0.05
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.8M
52W Range0.0375-0.3439
Volume244,000
Avg Volume162,667
Beta-0.07
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORobert Crandall Greene
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-29
Websitegeminalabs.com
3800 Westbrook Mall
Burnaby, BC V5G 4W8
CA
Burnaby, BC V5G 4W8
CA
604-760-1997
About Gemina Laboratories Ltd.
Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections. The company maintains its corporate headquarters in Vancouver, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found